Related references
Note: Only part of the references are listed.MiR-30c/PGC-1β protects against diabetic cardiomyopathy via PPARα
Zhongwei Yin et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Type 1 Diabetes-related Autoantibodies in Different Forms of Diabetes
Elin Pettersen Sorgjerd
CURRENT DIABETES REVIEWS (2019)
Serum miRNA levels are related to glucose homeostasis and islet autoantibodies in children with high risk for type 1 diabetes
Linda Akerman et al.
PLOS ONE (2018)
Elevated and Correlated Expressions of miR-24, miR-30d, miR-146a, and SFRP-4 in Human Abdominal Adipose Tissue Play a Role in Adiposity and Insulin Resistance
Yury O. Nunez Lopez et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2018)
Expression of miR-155, miR-146a, and miR-326 in T1D patients from Chile: relationship with autoimmunity and inflammatory markers
Diego F. Garcia-Diaz et al.
ARCHIVES OF ENDOCRINOLOGY METABOLISM (2018)
Immunological biomarkers for the development and progression of type 1 diabetes
Chantal Mathieu et al.
DIABETOLOGIA (2018)
Diabetes Modulates MicroRNAs 29b-3p, 29c-3p, 199a-5p and 532-3p Expression in Muscle: Possible Role in GLUT4 and HK2 Repression
Joao Esteves et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
MicroRNA expression profiles of human iPSCs differentiation into insulin-producing cells
Guido Sebastiani et al.
ACTA DIABETOLOGICA (2017)
Identification and Characterization of microRNAs Associated With Human β-Cell Loss in a Mouse Model
R. Roat et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
MicroRNA-126 overexpression rescues diabetes-induced impairment in efferocytosis of apoptotic cardiomyocytes
Sahana Suresh Babu et al.
SCIENTIFIC REPORTS (2016)
Circulating MicroRNAs Associate With Diabetic Nephropathy and Systemic Microvascular Damage and Normalize After Simultaneous Pancreas-Kidney Transplantation
R. Bijkerk et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
Richard A. Insel et al.
DIABETES CARE (2015)
Low levels of C-peptide have clinical significance for established Type 1 diabetes
W. M. Kuhtreiber et al.
DIABETIC MEDICINE (2015)
A comparative analysis of high-throughput platforms for validation of a circulating microRNA signature in diabetic retinopathy
Ryan J. Farr et al.
SCIENTIFIC REPORTS (2015)
Probe-based Real-time PCR Approaches for Quantitative Measurement of microRNAs
Wilson Wong et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2015)
Most People With Long-Duration Type 1 Diabetes in a Large Population-Based Study Are Insulin Microsecretors
Richard A. Oram et al.
DIABETES CARE (2015)
Prevalence of Detectable C-Peptide According to Age at Diagnosis and Duration of Type 1 Diabetes
Asa K. Davis et al.
DIABETES CARE (2015)
Robustness of Random Forest-based gene selection methods
Miron Bartosz Kursa
BMC BIOINFORMATICS (2014)
A genetic mouse model for progressive ablation and regeneration of insulin producing beta-cells
Farnaz Shamsi et al.
CELL CYCLE (2014)
Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes in the Diabetes Control and Complications Trial
John M. Lachin et al.
DIABETES (2014)
The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells
Richard A. Oram et al.
DIABETOLOGIA (2014)
Residual β-Cell Function 3-6 Years After Onset of Type 1 Diabetes Reduces Risk of Severe Hypoglycemia in Children and Adolescents
Jesper S. Sorensen et al.
DIABETES CARE (2013)
miR-25 and miR-92a regulate insulin I biosynthesis in rats
Dwi Setyowati Karolina et al.
RNA BIOLOGY (2013)
Retinal Vascular Geometry Predicts Incident Renal Dysfunction in Young People With Type 1 Diabetes
Paul Z. Benitez-Aguirre et al.
DIABETES CARE (2012)
Persistence of Prolonged C-peptide Production in Type 1 Diabetes as Measured With an Ultrasensitive C-peptide Assay
Limei Wang et al.
DIABETES CARE (2012)
Extended international (IOTF) body mass index cut-offs for thinness, overweight and obesity
T. J. Cole et al.
PEDIATRIC OBESITY (2012)
Retinal Vascular Geometry Predicts Incident Retinopathy in Young People With Type 1 Diabetes A prospective cohort study from adolescence
Paul Benitez-Aguirre et al.
DIABETES CARE (2011)
Protection From Retinopathy and Other Complications in Patients With Type 1 Diabetes of Extreme Duration The Joslin 50-Year Medalist Study
Jennifer K. Sun et al.
DIABETES CARE (2011)
Association Between Arterial Compliance and Age in Participants 9 to 77 Years Old
Andrew W. Gardner et al.
ANGIOLOGY (2010)
Residual Insulin Production and Pancreatic β-Cell Turnover After 50 Years of Diabetes: Joslin Medalist Study
Hillary A. Keenan et al.
DIABETES (2010)
Preservation of β-Cell Function in Autoantibody-Positive Youth With Diabetes
Carla J. Greenbaum et al.
DIABETES CARE (2009)
Extent of Beta Cell Destruction Is Important but Insufficient to Predict the Onset of Type 1 Diabetes Mellitus
David J. Klinke
PLOS ONE (2008)
β-cell function and the development of diabetes-related complications in the diabetes control and complications trial
MW Steffes et al.
DIABETES CARE (2003)
Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients
MM Zanone et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2003)
Reduced arterial elasticity in rheumatoid arthritis and the relationship to vascular disease risk factors and inflammation
M Wong et al.
ARTHRITIS AND RHEUMATISM (2003)
Share Paper
